Free Trial

kneat.com (TSE:KSI) Shares Up 4.4% - Still a Buy?

kneat.com logo with Medical background

Key Points

  • kneat.com, inc. (TSE:KSI) shares increased by 4.4% on Monday, closing at C$5.41 after trading as high as C$5.45, with trading volume up by 29% from the average.
  • Analysts have set a new price objective for kneat.com at C$7.00, down from C$7.50, with a consensus rating of "Buy" and an average price target of C$6.50.
  • The company specializes in developing software for regulated data-intensive processes in the life sciences sector, featuring its Kneat Gx solution to enhance compliance and quality management.
  • Interested in kneat.com? Here are five stocks we like better.

kneat.com, inc. (TSE:KSI - Get Free Report)'s stock price shot up 4.4% on Monday . The stock traded as high as C$5.45 and last traded at C$5.41. 123,526 shares traded hands during trading, an increase of 29% from the average session volume of 95,609 shares. The stock had previously closed at C$5.18.

Analysts Set New Price Targets

Separately, Raymond James Financial reduced their price objective on shares of kneat.com from C$7.50 to C$7.00 and set an "outperform" rating for the company in a research note on Wednesday, August 6th. One equities research analyst has rated the stock with a Strong Buy rating and two have assigned a Buy rating to the company's stock. According to data from MarketBeat.com, the company presently has an average rating of "Buy" and a consensus price target of C$6.50.

Read Our Latest Stock Analysis on KSI

kneat.com Stock Up 4.4%

The firm has a market capitalization of C$514.05 million, a PE ratio of 541.00, a price-to-earnings-growth ratio of 597.67 and a beta of 1.45. The business's 50-day moving average price is C$5.76 and its 200-day moving average price is C$6.13. The company has a quick ratio of 1.50, a current ratio of 1.43 and a debt-to-equity ratio of 85.50.

About kneat.com

(Get Free Report)

kneat.com Inc is in the business of developing and marketing a software application for modelling regulated data-intensive processes for regulated industries, focusing on the life sciences industry. The company has developed Kneat Gx solution which provides management real-time visibility and control and increases product, quality, and compliance.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in kneat.com Right Now?

Before you consider kneat.com, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and kneat.com wasn't on the list.

While kneat.com currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Markets Are Sliding: Where to Find Opportunity
5 Hot Stocks to Buy Now: September’s Top Picks With Major Momentum
$15 Billion for Cybersecurity: The Government’s Next Big Push

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines